Dossier
Christophe Bourdon
Coverage of Christophe Bourdon in the Nexus archive.
- Do we want to lead or lag in life sciences?
Europe risks losing its leadership in the pharmaceutical sector due to geopolitical challenges and internal indifference, with the United States' Most-Favored-Nation pricing policy and China's rapid advancements in biotechnology and innovation exacerbating the decline. Europe lags behind in clinical trials, R&D spending, and attracting investment compared to the US and China.